Maintenance of recovered dilated cardiomyopathy patients with half-dose neurohumoral blockades (MED-CHARM): A protocol for an open-label, pilot, randomized trial

Dilated cardiomyopathy (DCM) has brought great damage to the patients' health and social economy. The number of patients with recovered dilated cardiomyopathy (recDCM) has increased over the years as treatment progresses. However, there is a lack of relevant evidence to support the clinical man...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pengda, Luo, Xiaolin, Hou, Changchun, Wu, Shaofa, Wang, Luyu, Sun, Ning, Wang, Zebi, Wang, Zelan, Jin, Jun, Wang, Jiang, Qin, Zhexue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412028/
https://www.ncbi.nlm.nih.gov/pubmed/36035935
http://dx.doi.org/10.3389/fcvm.2022.966537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412028/
https://www.ncbi.nlm.nih.gov/pubmed/36035935
http://dx.doi.org/10.3389/fcvm.2022.966537

Ejemplares similares